Corlopam dopamine DA1 agonist: A Phase II trial has been completed

Neurex Corp. (NXCO), Menlo Park, Calif.
Product:

Read the full 73 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE